Casirivimab (Synonyms: REGN10933) |
| Catalog No.GC68834 |
Casirivimab (REGN10933) is a human monoclonal antibody that targets the SARS-CoV-2 virus that causes COVID-19. Casirivimab lacks efficacy against COVID-19 variants. Casirivimab can be used in combination with Imdevimab to effectively reduce viral load and improve symptoms.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2415933-42-3
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Casirivimab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Casirivimab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *